Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MSA:ICG (Korea Univ. Guro Hospital): sourced facts only. name: "The aim of this study was to evaluate the effectiveness of indocyanine green-neomannosyl human serum albumin (MSA:ICG) which targets macrophage mannose receptor CD206 for SLN mapping." [DOI:10.1158/1538-7445.am2023-2385]; target: "The aim of this study was to evaluate the effectiveness of indocyanine green-neomannosyl human serum albumin (MSA:ICG) which targets macrophage mannose receptor CD206 for SLN mapping." [DOI:10.1158/1538-7445.am2023-2385]; developer: "1Korea University Guro Hospital, Seoul, Republic of Korea." [DOI:10.1158/1538-7445.am2023-2385]; stage: "LN targeting ability was examined on mouse footpad models of uterine cancer using MSA:ICG and ICG for comparison." [DOI:10.1158/1538-7445.am2023-2385]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MSA:ICG (Korea Univ. Guro Hospital).